Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of NicVAX co-administered
with varenicline as an aid in smoking cessation over a one-year period in smokers who want to
quit smoking.
Phase:
Phase 2
Details
Lead Sponsor:
Maastricht University Medical Center
Collaborators:
Nabi Biopharmaceuticals ZonMw: The Netherlands Organisation for Health Research and Development